Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution. - Wikidata - awgldk - TriplyDB

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

http://www.wikidata.org/entity/Q37649196

about

Renal Injury during Long-Term Crizotinib Therapy

P2860

Q59133910-FA39C8E7-48AD-4B61-9B3C-9F518B1C7F51

P2860

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

http://www.wikidata.org/entity/Q37649196

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@en

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@nl

type

label

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@en

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@nl

prefLabel

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@en

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@nl

P1433

Q37649196-82E12546-9B44-4A04-9BAC-6BD9FD68A18B

P1476

Q37649196-C8998038-BEBE-488C-BF1F-CF5AC9DA68A3

P2093

Q37649196-0540F7D2-E9EA-447E-9357-71B45F80C5B1

Q37649196-074F8B2C-20E2-4EEB-8B24-75A346A481DD

Q37649196-3C14F968-6B68-43BC-A987-6600609D947A

Q37649196-909B6A41-4E7F-43EF-AC4E-1A899D1809E8

Q37649196-92591322-74E8-4D6F-8801-89AA899C190C

Q37649196-F02A8D30-F774-4825-95C5-78602A05E12E

P2860

Q37649196-167E48B9-39BB-4557-BC88-EDE7C78ADDED

Q37649196-184F06C0-4695-4F1C-A296-0852B239D001

Q37649196-21C2F4E0-01FD-44BE-813D-30A21E637602

Q37649196-27941B58-651E-4CBF-8EF7-58CD9F50B39F

Q37649196-2D5222CA-92D1-4E45-ADAD-4A403DBCCB2A

Q37649196-2DD7556E-8E25-4D8A-802F-D18990018451

Q37649196-2F306971-D590-46C8-B3AE-5FDB482FB86E

Q37649196-308177B3-B4A4-4B68-876D-391FD5ADC9C6

Q37649196-41A7B76E-3738-4662-AE14-56CDB7AD73FF

Q37649196-5243A509-1DFC-4691-8215-D564FD994A3B

P2888

Q37649196-ABB185D6-7BB5-4F1A-B615-5434BC5B0907

P304

Q37649196-FB893035-7660-40E1-AC25-80F7FD837369

P31

Q37649196-9C25D89B-0014-4F8A-8D76-F48301122CC2

P356

Q37649196-56B50E2E-1AE5-43B9-A835-F0C0F269AC48

P433

Q37649196-83DB9066-834B-4901-823C-34CEFBA6AE34

P478

Q37649196-72BFED3B-F48F-48EE-B184-628B9B7ED107

P577

Q37649196-DAEA539E-8843-4193-B1CF-0D89F0D79291

P6179

Q37649196-38E37A3F-DDFD-4828-A446-8B12AE51119E

P698

Q37649196-4F077555-D879-4631-9281-264E20D4215E

P921

Q37649196-CB43E4C5-7537-419F-A8D1-CD8AC0D79C7D

P932

Q37649196-0D0C7AE2-1E22-44BC-9B50-7DE5CCDED5F9

P356

S40644-017-0109-5

P1433

P1476

Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

@en

P2093

Benjamin Solomon

http://www.w3.org/2001/XMLSchema#string

Bimal Kumar Parameswaran

http://www.w3.org/2001/XMLSchema#string

Catherine Mitchell

http://www.w3.org/2001/XMLSchema#string

Damian H S Jiang

http://www.w3.org/2001/XMLSchema#string

Kate Moodie

http://www.w3.org/2001/XMLSchema#string

Laird B Cameron

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Second- and third-generation ALK inhibitors for non-small cell lung cancer

Cystic renal masses: accurate Bosniak classification requires adequate renal CT.

Spontaneous regression of crizotinib-associated complex renal cysts during continuous crizotinib treatment

Complex renal cysts associated with crizotinib treatment

The Bosniak classification of renal cystic masses.

Imaging features of renal complications after crizotinib treatment for non-small-cell lung cancer: a case report.

P2888

s40644-017-0109-5

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40644-017-0109-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083845016

http://www.w3.org/2001/XMLSchema#string

P698

28209203

http://www.w3.org/2001/XMLSchema#string

P921

P932

5314638

http://www.w3.org/2001/XMLSchema#string